🇺🇸 FDA

Company profile · Sponsor

Silence

Silence Therapeutics plc

SLN · NYSE pharma LONDON, USA
Pipeline
8
Drugs
0
Patents
3

Quick answer

Silence (SLN) is a pharma company. headquartered in LONDON, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker SLN
Exchange NYSE
Company type pharma
Headquarters LONDON, USA
SEC CIK 0001479615

Pipeline (8)

Search pipeline →

  1. Atu027 & gemcitabine in lead in safety period

    Silence

    Carcinoma, Pancreatic Ductal

    phase 2 small molecule completed

    1 trial

  2. SLN124

    Silence

    Polycythemia Vera

    phase 2 small molecule active

    1 trial

  3. SLN360

    Silence

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  4. Atu027

    Silence

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  5. SLN124

    Silence

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule completed

    1 trial

  6. SLN124

    Silence

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo

    Silence

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule terminated

    1 trial

  8. SLN360

    Silence

    Hyperlipidemias

    phase 1 small molecule completed

    1 trial

Patents (3)

Search patents →

  1. US 12338438

    Conjugated oligonucleotide compounds, methods of making and uses thereof

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10961238

    Modulators of hedgehog (Hh) signaling pathway

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8614179

    Antibacterial combination therapy for the treatment of gram positive bacterial infections

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Silence?

Silence (SLN) is a pharma company. headquartered in LONDON, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..

What pipeline programs does Silence sponsor?

We track 8 ClinicalTrials.gov-linked programs for Silence, including Atu027 & gemcitabine in lead in safety period and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Silence company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.